Adult stem cells maintain and repair tissues in health and disease. As such, these cells must sense and respond to environmental assaults. Epithelial barriers are especially vulnerable as they are exposed to a range of commensal and pathogenic microorganisms and noxious agents. How epithelial tissues, and in particular their long-lived stem cells, respond to and cope with recurrent inflammation-provoking signals is unknown. EpSCs, housed in the innermost (basal) layer of skin epithelium, can self-renew and also execute a terminal differentiation program that generates a constant upward flux of barrier cells 1,2 . Defined niche factors emanating from the basement membrane and underlying dermis induce molecular programs that maintain EpSC identity and lineage commitment 3,4 . How EpSCs endure assaults and restore normalcy is less clear, and yet their ability to do so is vital for survival. Here, we focused on how skin epithelial stem cells respond to inflammatory stimuli. In doing so, we uncovered a capacity of EpSCs to learn from their experience for the sake of long-term tissue fitness and function.
Adult stem cells maintain and repair tissues in health and disease. As such, these cells must sense and respond to environmental assaults. Epithelial barriers are especially vulnerable as they are exposed to a range of commensal and pathogenic microorganisms and noxious agents. How epithelial tissues, and in particular their long-lived stem cells, respond to and cope with recurrent inflammation-provoking signals is unknown. EpSCs, housed in the innermost (basal) layer of skin epithelium, can self-renew and also execute a terminal differentiation program that generates a constant upward flux of barrier cells 1, 2 . Defined niche factors emanating from the basement membrane and underlying dermis induce molecular programs that maintain EpSC identity and lineage commitment 3, 4 . How EpSCs endure assaults and restore normalcy is less clear, and yet their ability to do so is vital for survival. Here, we focused on how skin epithelial stem cells respond to inflammatory stimuli. In doing so, we uncovered a capacity of EpSCs to learn from their experience for the sake of long-term tissue fitness and function.
Lineage-tracing EpSCs in inflammation
To examine how stem cells are impacted by inflammation, we used a model of skin inflammation induced by toll-like receptor 7 (TLR7) and the NALP3 agonist imiquimod (IMQ) [5] [6] [7] . In agreement with previous reports 6 , topical application of IMQ elicited hyperthickening and parakeratosis primarily within the epidermis and the upper hair follicle (infundibulum), accompanied by EpSC hyperproliferation and apoptosis, which peaked at day 6 ( Fig. 1a and Extended Data Fig. 1a) . By day 30, these notable perturbations had subsided.
Given these self-resolving features, we wondered whether day 6 inflammation-sensitized stem cells and/or their progeny contribute to epidermal homeostasis after resolution of inflammation. To track stem-cell dynamics, we used inducible-marker based fate mapping 2 with Rosa-LSL-YFP reporter mice that contain the Cre recombinaseoestrogen receptor fusion protein (CreER) driven by the Krt14 or Krt10 promoter. Keratin 14 (K14) is present in all skin EpSCs, and at low doses of tamoxifen, Krt14-creER preferentially labels EpSCs of the epidermis (and infundibulum). By contrast, Krt10-creER is expressed in differentiating layers (Extended Data Fig. 1b) .
Tamoxifen-treated Krt14-creER;Rosa-LSL-YFP mice 8 were topically treated with IMQ and lineage-traced. YFP + cells persisted in the IMQtreated skin at equivalent numbers to naive (vehicle control) skin for up to 180 days after inflammation (Extended Data Fig. 1b, c) . Because Cre recombinase was not activated without tamoxifen (Extended Data Fig. 1d ), the YFP + EpSCs were long-lived and had survived the inflammatory assault. By contrast, Krt10-creER-activated YFP + cells (although present initially) were shed within 6 days, indicating that once progenitors commit to terminal differentiation, they do not revert even in response to IMQ (Extended Data Fig. 1b, e) .
Enhanced wound healing after inflammation
The persistence of inflammation-experienced EpSCs long after the restoration of homeostasis led us to address whether this assault may have had a lasting effect on them and/or their microenvironment. We therefore challenged inflammation-recovered skin with a secondary assault, in this case wounding. Notably, the post-inflamed mice closed their wounds approximately 2.5 times faster than naive mice. The enhanced wound-healing response by inflammation-experienced skin occurred even when the initial assault had occurred 180 days earlier ( Fig. 1b and Extended Data Fig. 2a, b) .
To determine whether this heightened sensitivity might be triggered by other inflammatory stimuli, we replaced IMQ with various other treatments such as topical application of the vitamin D analogue calcipotriol (MC903; to model atopic dermatitis) 9 ; topical application of 12-O-tetradecanoylphorbol 13-acetate (TPA; to induce hyperplasia) 10 ; epidermal abrasion wounding 11 Inflammation-experienced skin displayed enhanced epidermal thickness and accelerated re-epithelialization, but showed similar rates of proliferation (Fig. 1d , e and Extended Data Fig. 2d ). Re-epithelialization by the migrating K14
+ and integrin α 5 + epidermal tongue neared completion by day 5 in wounded post-inflamed skin, and healed 2 days faster than in naive counterparts.
To exclude myofibroblast-mediated dermal contraction as a notable contributor to the augmented wound closure after inflammation, we affixed a silicone splint around full-thickness wounds 14 . Inflammationexperienced mice still exhibited enhanced re-epithelialization and accelerated wound repair ( Fig. 1f and Extended Data Fig. 2e) . Moreover, using an assay that specifically measures keratinocyte migration (Extended Data Fig. 2f ), we found that keratinocyte outgrowth from ex vivo explants after inflammation 13 was more robust than in controls (Fig. 1g) . These findings suggest that inflammation induces long-term changes in EpSCs that enhance their capacity to react swiftly to a secondary assault.
IMQ intrinsically sensitizes EpSCs
EpSCs receive cues from their local milieu as well as from infiltrating immune cells and circulating factors that direct wound repair. Thus, we evaluated the relative importance of these secondary effectors on the sensitization of inflammation-experienced skin to wounding. When IMQ was applied to half of the dorsal skin, the pathology remained restricted to the treatment site (local), and upon subsequent wounding, distal sites closed comparably to control skin (Fig. 2a, b and Extended Data Fig. 3a) . Thus, the EpSC memory of inflammation was not transmitted through systemic (circulating) factors to naive sites.
We next tested whether the heightened responsiveness of inflammation-experienced EpSCs was secondarily dependent on the memory of resident innate and adaptive immune cells 15 . CD45
+ cells including innate immune cells such as Langerhans cells, dermal dendritic cells, macrophages, and eosinophils and adaptive immune cells such as dendritic epidermal γδ T cells (γδ T cell receptor (TCR)
), returned to normal levels by day 30 after inflammation (Extended Data Fig. 3b, c) . Moreover, the depletion of skin-resident macrophages before wounding showed no obvious effect on the wound repair advantage displayed by EpSCs after inflammation (Fig. 2c) .
The initial psoriatic-like response triggered by IMQ is dependent on dermal γ δ TCR low T cells that express retinoic acid receptor-related orphan receptor C (RORC) 7 (Fig. 2d ). In addition, relative to control, RORC + adaptive immune cells were increased in IMQ-treated skin both at the peak of inflammation (5.0 times) and in post-inflamed skin (1.8 times) and localized in close proximity to the epidermis and hair follicles ( Fig. 2e and Extended Data Fig. 3d, e) .
Consistent with the involvement of tissue-resident T cells in wound repair and pathogen responses 12, 16 , wounds closed slower when inflammation-experienced or naive skin was depleted of its RORC + lymphocytes. Notably, however, even after RORC + cell depletion, inflammation-experienced skin still closed wounds approximately twice as fast as naive skin counterparts. Moreover Rag2-null mice, which mount an inflammatory response to IMQ despite the absence of B and T cells 7 , also exhibited faster wound closure after inflammation than naive skin (Fig. 2f-h and Extended Data Fig. 3f-i) .
EpSC memory at the chromatin level
Memory of previous exposure to inflammatory stimuli has long been thought to be exclusive to immune cells. We posited that the heightened responsiveness of post-inflamed EpSCs to tissue damage may involve chromatin dynamics analogous to those recently described for innate immune memory 17 . To this end, we purified epidermal EpSCs from IMQ-treated skin at the zenith of inflammation (day 6) and after their return to normal homeostasis (days 30 and 180) (Extended Data Fig. 4a-c) . We then used assay for transposase accessible chromatin with high-throughput sequencing (ATAC-seq) analysis 18 . Agnostic to specific types of epigenetic modifications, this strategy enables global identification of accessible chromatin states.
Independent biological replicates showed strong correlation (R 2 ≥ 0.97). ATAC-seq signals were enriched at transcription start sites (TSSs) and distal regulatory element CCCTC-binding factor a, IMQ treatment schematic and corresponding histopathology (n = 3; * * * P < 0.0001). EdU + basal epidermal and infundibulum cells (n = 3; * P = 0.01). Ctrl, control; D, day; DAPI, 4′ ,6-diamidino-2-phenylindole. b, Accelerated wound-healing response in skin 30 days (n = 17; * * * P < 0.0001) or 180 days (n = 5; * * * P = 0.0003) postinflammation (PI) versus control skin (images n = 3). Rate calculated from wound area: day 30, see adjacent graph; day 180, see Extended Data Fig. 2b . For individual data points, see Source Data. c, Accelerated woundclosure response, irrespective of the initial inflammatory stimulus (n ≥ 4). IMQ, * * * P < 0.0001; MC903 (also known as calcipotriol), * * * P = 0.0001; TPA, * * P = 0.0014; epidermal abrasion wound, * * P = 0.0027; infection with 10 6 fungal cells (C. albicans) * * P = 0.0029. Rate calculated from wound area in Extended Data Fig. 2c . d, Accelerated re-epithelialization in skin exposed to inflammation (n = 3). Lines denote initial wound edges, arrows mark the edge of the wound bed (WB). e, Quantification of migrating epithelial tongue, determined by the length of K14 + integrin α 5 + cells (n = 4; * P = 0.034 (day 3), * * P = 0.037 (day 5)) (left) and the percentage of proliferating wound-edge basal EpSCs, determined by number of K14
+ EdU + cells per number of K17 + cells (n ≥ 2) (right). f, Wound closure of silicone-splinted, 3 mm full-thickness wounds (n = 3; * * * P < 0.0001 (day 5), * P = 0.0374 (day 10)). g, Analysis of K14 + keratinocyte outgrowth from day 10 ex vivo explants. Yellow and red lines mark outgrowth boundary and distance, respectively (n ≥ 14; * * * P = 0.0006). Scale bars, 50 μ m (a, EdU), 200 μ m (a, histology, d), 2 mm (b) and 500 μ m (g). Data are mean ± s.e.m. n denotes the number of biologically independent animals. Experiments replicated twice and significance determined by two-tailed t-test (95% confidence). NS, not significant (P > 0.05).
(CTCF) sites, and were similarly distributed over various genomic and intergenic regions in all samples (Extended Data Fig. 4d, e) . Although EpSC-specific genes, such as Klf5 and Krt14, showed similar chromatin accessibility patterns, notable differences were seen between the day 6 IMQ-treated and control EpSCs ( Fig. 3a and Extended Data Fig. 4f-h for key epidermal transcription factors (such as AP-1 (Jun, Fos and ATF members), AP2γ , KLF5, ETS2, GRHL2/3 and p63), as well as factors such as NF-κ B and STAT1/3, the activation of which has been associated with inflammation. By day 30 after IMQ exposure, many peaks had resolved. Notably, however, more than 2,000 IMQ-induced peaks were maintained, suggestive of an epigenetic memory. Some peaks were even present at day 180, long after inflammation had resolved. PANTHER pathway analysis of their assigned genes revealed enrichment for inflammation-and hyperproliferation-associated pathways, including apoptosis signalling, interleukin signalling, oxidative stress response, RAS and PI3 kinase pathways (Fig. 3a-d and Extended Data Fig. 4g ).
DNA sequences enriched for both epidermal and inflammationinduced transcription factor motifs were associated with peaks persisting after inflammation (Fig. 3e) . STAT3 was notable as it is known to be phosphorylated and activated after IMQ treatment 7 . Although it was re-activated in the secondary wound response, STAT3 activity was not maintained during the interim (Fig. 3f) .
Inflammation-sensing chromatin elements
Our data thus far suggest that inflammation-activated transcription factors facilitate the initial opening of certain chromatin domains, which then bind epidermal transcription factors and other chromatin modifiers present in both inflammatory/stress and post-inflamed/homeostatic states. The model further predicts that domains maintained after inflammation should serve as accessible platforms for accelerated re-activation upon a secondary assault (Fig. 4a) .
We tested two important facets of this model. First, we interrogated the ability of these persisting chromatin peaks to function as inflammation-sensing elements. Using our EpSC-specific in utero lentiviral delivery method 22 (Methods), we engineered mice containing the Pgk-H2B-RFP and eGFP transgenes driven by one of several accessible genomic regions sustained post-inflammation. By contrast with Pgk-H2B-RFP, expressed throughout virally transduced skin epithelium, the eGFP reporters were not activated until IMQ was administered, underscoring their potential to act as sensors of tissue damage (Fig. 4b) .
If the persisting open chromatin domains after inflammation are physiologically relevant to the functional EpSC memory, then they should participate in the accelerated wound-repair response that we observe in inflammation-experienced mice. To test this possibility, we wounded the skin of day 30 post-inflamed mice, and 12 h later we evaluated the transcriptional response of EpSCs within an approximately 0.5 mm 2 radius of the wound edge. In parallel, we transcriptionally profiled the epidermal EpSCs from control and IMQtreated skins at days 6 and 30 after inflammation.
In line with the epidermal pathology, EpSCs from day 6 IMQtreated skin displayed notable changes in the transcriptome relative to control counterparts. Changes correlated well with genes featuring newly acquired ATAC-seq peaks (Fig. 4c and Extended Data Fig. 5a-c) . Although only a few of these genes were still transcribed at day 30 (false discovery rate (FDR) < 0.05), this picture changed rapidly + cells (flow cytometry, n = 4, * * * P = 0.0008). Schematic of RORC + T cell depletion and wound repair using Rosa-LSL-iDTR (control) and Rorc-cre;Rosa-LSL-iDTR (Rorc-DTR) mice, which activate the diphtheria toxin receptor (DTR) from the Rosa26 locus only in RORC + cells, enabling their selective ablation (n = 5; * * P = 0.005 (control), * * P = 0.0053 (Rorc-DTR)). g, h, Rag2-null mice mount an IMQ response (n = 3, 3 images per animal) (g) and display accelerated wound healing (h) at 30 days after inflammation (n = 5, * P = 0.0136). Rate calculated from wound area: b, Extended Data Fig. 3a ; c, see Source Data; g Extended Data Fig. 3h ; h, Extended Data Fig. 3i . Data are mean ± s.e.m. Scale bars, 200 μ m (a) and 50 μ m (e, g). n denotes the number of biologically independent animals. Experiments replicated at least twice, and significance was determined using a two-tailed t-test (95% confidence). ). c, Snapshot of genomic loci in which the chromatinaccessible peaks are opened by inflammation at day 6 and persist up to 180 days after resolution. d, PANTHER pathways analysis of 2,041 shared, inflammation-induced peaks between day 6 IMQ and day 30 post-IMQ EpSCs. e, Transcription factor motif enrichment within shared peaks in b (n = 3, cumulative binomial distributions, P < 10
−12
). f, Epidermal STAT3 activation (pSTAT3(Tyr705)) in day 6 inflamed and day 30 post-inflamed skin 12 h after wounding, but not in day 30 post-inflamed unwounded skin (n = 3). Scale bars, 50 μ m. n denotes the number of biologically independent animals. Experiments replicated at least twice. with chromatin-accessible domains that were unique to post-inflamed EpSCs (random permutation, P < 10 −4 ). e, Ingenuity pathways analysis of upregulated transcripts in post-inflamed 12 h wound-edge EpSCs relative to control cells (n = 4, P values determined by right-tailed Fisher's exact test). f, Increased Aim2 transcription associated with inflammation, memory and rapid wound response in post-inflamed skin, post-wounding (PW) (n ≥ 2, two-tailed t-test, day 6 and 12 h postwounding, * * * P < 0.0001; day 180, * * * P = 0.0001). g, Aim2-null mice do not show enhanced wound healing after inflammation (n ≥ 2, two-tailed t-test, * * * P = 0.0002). KO, knockout. h, Overexpression (OE) of epithelial Aim2 is sufficient to augment wound healing in naive mice (n = 2). Data are mean ± s.e.m. Rate calculated from wound area: g, Extended Data Fig. 4e ; h, Extended Data Fig. 4f . TRE, tetracycline response element. n denotes the number of biologically independent animals. Experiments replicated at least twice.
upon wounding (Fig. 4c, d ). Of the 140 genes upregulated within 12 h after injury, 73 (52%) were associated with ATAC-seq peaks that were acquired during and sustained after IMQ treatment (FDR < 0.05). Given that wound re-epithelialization did not peak until day 5 after wounding, this early activation of genes associated with inflammationexperienced chromatin accessible regions was notable.
Downstream effectors of EpSC memory
To understand how these 'inflammatory memory' chromatin elements might confer a wound repair advantage, we first performed pathway analysis of the rapid-response transcripts (adjusted P value < 0.05) of the genes that contain these chromatin elements.Within the top terms was 'inflammasome signalling' (Fig. 4e ). This included not only AIM2 23 , previously implicated in skin disease and cancer 24,25 , but also other downstream components of the AIM2 inflammasome. AIM2 was particularly intriguing in that its transcript was sustained in EpSCs at days 30 and 180 after inflammation, and also increased after wounding (Fig. 4c, f) . Consistent with our finding that the EpSC memory response did not rely on RORC + cells, Aim2 was sustained in inflammation-experienced skin depleted of its RORC population (Extended Data Fig. 5d ).
Loss-and gain-of-function studies revealed a role for AIM2 in endowing inflammation-experienced EpSCs with their heightened sensitivity to a secondary assault. Aim2-null mice failed to show an inflammation-experienced wound repair advantage ( Fig. 4g and Extended Data Fig. 5e ). Furthermore, when we engineered and tested mice whose skin epithelium contained a lentiviral-transduced, doxycycline-inducible Aim2 cDNA (TRE-Aim2), we discovered that in the absence of IMQ preconditioning, increased expression of Aim2 was sufficient to augment wound repair ( Fig. 4h and Extended Data Fig. 5f ). Altogether, these data underscore a role for AIM2 as a key mediator of the wound repair advantage in post-inflamed EpSCs.
In the intestine, AIM2 suppresses stem-cell proliferation 26,27 by indirectly inhibiting phosphorylated AKT(Ser473) (Extended Data Fig. 6a ). However, in the epidermis, post-inflamed wounds had higher levels of pAKT(Ser473) and equivalent numbers of proliferating EpSCs to control wounds ( Fig. 1e and Extended Data Figs 2d, 6b). Therefore, we focused on the role of AIM2 in the inflammasome pathway that is triggered after infection or tissue damage 24, 28 . A central downstream effector of AIM2 is caspase-1 (CASP1). CASP1 transcription and activity were initiated quickly within 12 h of injury in post-inflamed samples relative to naive skin (Fig. 5a) . Moreover, when the activity of CASP1 was blocked by the inhibitor AC-YVAD-cmk 29 , rates of wound healing were unaffected in naive skin, and reduced to naive levels in inflammation-experienced skin ( Fig. 5b and Extended Data Fig. 6c ). This was not attributable to CASP1-dependent pyroptosis, as both control and post-inflamed wound edge EpSCs exhibited minimal and equivalent levels of cell death (Extended Data Fig. 6d ).
CASP1 promotes the maturation and secretion of the pro-inflammatory cytokines IL-18 and IL-1β . Indeed, post-inflamed skin displayed increases in Il18 transcription and in the levels of IL-18 and IL-1β proteins compared with naive skin (Fig. 5c ). To determine whether AIM2 acts through cytokine production to accelerate wound repair, we repeated our experiments with Il18-and Il1r1-null mice. Although IL-18 was dispensable, without IL-1R1, which is required for IL-1β signalling, inflammation-experienced skin failed to enhance wound repair (Fig. 5d , e and Extended Data Fig. 6e , f). Consistent with these findings, the addition of recombinant IL-1β , but not IL-18, enhanced the migration of keratinocytes from naive skin explants (Fig. 5f ). Conversely, when doxycycline-treated TRE-Aim2 mice were injected with IL-1R1-blocking antibodies, their rate of wound closure was comparable to that seen in untreated, naive control mice ( Fig. 5g and Extended Data Fig. 6f ). Taken together, these data point to AIM2 and its downstream effectors CASP1 and IL-1β as central regulators of the heightened wound-repair response seen in inflammation-experienced skin (Fig. 5h) .
Discussion
Tissue adaptation to inflammation has been attributed to innate memory within macrophages and natural killer cells, and to persisting tissue-resident memory T cells 16, 17 . It was therefore surprising to find that inflammatory memory is also an intrinsic feature of long-lived EpSCs, enabling them to respond more rapidly to a secondary assault. Analysis of the myriad of potential contributing factors offers areas for future research. For instance, although the overall numbers of basal skin cells remained unchanged, distinct pools of EpSC that do not participate in naive skin responses might become sensitized to do so as a result of inflammation. Our current study builds on a pre-existing mechanistic model for memory T cells and trained innate immune cells 16, 17 , namely that EpSCs 'remember' a primary inflammatory stimulus by maintaining certain changes to their chromosomal inflammasome in enhancing wound re-epithelialization of inflammation-experienced skin. a, Increased levels of the Casp1 transcript (* * P = 0.0025) and CASP1 activity (* * P = 0.0014) in day 30 post-inflamed skin, 12 h after wounding (n = 3). b, Schematic depicts the experiment. Ac-YVAD-cmk reduces CASP1 activity (left) and the wound repair rate (right) after inflammation to the levels of control wounds (CASP1 activity n = 2, wound repair n = 5). * * P = 0.0018. c, Increased levels of the Il18 transcript (n = 3; * * P = 0.0014), IL-18 protein (n = 4; * P = 0.0202) and IL-1β protein (n = 3; * * P = 0.0073) in post-inflamed skin after wounding, but not of the Il1b transcript (n = 2). d, Enhanced injury response of post-inflamed skin in the absence of Il18 (n = 3, * P = 0.0146 (WT); * * P = 0.0019 (KO)). e, The absence of IL-1β signalling, achieved in Il1r1-null mice, abrogates the enhanced injury response of post-inflamed skin (n = 4; * P = 0.0155 (WT); * * P = 0.0086 (KO)). f, Recombinant IL-1β , but not IL-18 (50 ng ml −1 ), accelerates the outgrowth of K14 + keratinocytes in day 5 ex vivo skin explants. Dotted and red lines mark outgrowth border and distance, respectively (n = 3; 3 technical replicates per mouse, * P = 0.0128). Scale bar, 500 μ m. g, Intraperitoneal (i.p.) treatment with anti-IL-1R1 reverses the wound repair advantage conferred by overexpression of epidermal Aim2 in naive mice (n = 3; * * P = 0.0055 (control IgG), * * * P = 0.0007 (anti-IL-1R1)). h, Summary of the downstream AIM2 effectors in post-inflamed skin. ASC, apoptosis-associated speck-like protein containing a CARD. Rate calculated from wound area: b, Extended Data Fig. 6d ; d, Extended Data Fig. 6e ; e, Extended Data Fig. 6f ; g, Extended Data Fig. 6g . Data are mean ± s.e.m. n denotes the number of biologically independent animals. Experiments in a-f replicated at least twice, experiment in g performed once. Significance determined using two-tailed t-test (95% confidence).
Article reSeArcH landscape that were induced at the time of assault. We show that these changes endow EpSCs with the ability to accelerate their response to subsequent stressors.
Most chromatin changes maintained in EpSCs after IMQ treatment were not accompanied by sustained transcription of their associated genes, nor did inflammation-induced transcription factors remain active. Because inflammation was necessary to render these chromatin domains accessible and yet not to maintain them once opened, the evidence indicates that EpSC transcription factors and other chromatin modifiers present in normal homeostasis can propagate these chromatin sites made accessible during inflammation.
Although the underlying mechanisms are complex, our reporter analyses indicate that sustained open-chromatin domains possess the information needed to sense tissue damage. Moreover, by remaining open long after the inflammation resolves, these sensors seem to have functional relevance in a secondary assault. Consistent with this notion, more than half of the genes induced early and selectively at the wound edge of inflammation-experienced skin were associated with these sustained open-chromatin domains.
The inflammasome pathway was featured prominently among these rapid responders. Our gain-and loss-of-function studies with AIM2, CASP1, IL-1β and IL-1R1 underscore the importance of this pathway in conferring a wound repair advantage to inflammation-experienced EpSCs. Notably, intestinal epithelial cells can also sense tissue damage and they express AIM2
28
, raising the tantalizing possibility that EpSCs in other tissues possess a similar AIM2 inflammasome-mediated memory of a primary assault.
As beneficial as it may seem to retain inflammatory memory in order to hasten barrier restoration the next time a breach occurs, heightened sensitivity to tissue damage may not always be a blessing. Genetic alterations that mobilize stem cells more rapidly are often associated not only with accelerated wound repair, but also with increased susceptibility to cancer 30 . Indeed, individuals with gain-of-function mutations in inflammasome components can show increased risk of epidermal cancers 31, 32 . Our findings suggest that the inflammation-experienced memory in EpSCs may also underlie the recurrent skin inflammation displayed by patients with autoimmune disorders such as psoriasis and atopic dermatitis. Overall, the inflammation-induced rewiring of EpSCs that we report is likely to have major implications for future therapeutic agents aimed at enhancing adaptive features and counteracting maladaptive ones.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. were a gift from G. Eberl. Tg(Ly6a-Cre)1Isg mice 35 were a gift from I. SanchezGarcia. Krt14-creER 8 and Krt14-rtTA 36 mice were previously generated in the Fuchs laboratory. Krt10-creER transgenic mice were generated by retrieving the mouse Krt10 promoter region (8,416 bp fragment upstream of the Krt10 start codon) from bacterial artificial chromatin DNA (CHORI clone RP23-336D20) and then inserting it upstream of the β -globin intron-creER-polyA, analogous to our Krt14-creER 8 transgene. All keratin promoter-driven CreER mice were then each crossed to Rosa26-Flox-Stop-Flox-YFP mice 37 . All animal studies were approved by the Institutional Animal Care and Use Committee. Mice were bred and maintained under specific-pathogen-free conditions at the AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care International)-accredited Comparative Bioscience Center at the Rockefeller University and housed in accordance with the procedures outlined in the Guide for the Care and Use of Laboratory Animals. When possible, preliminary experiments were performed to determine requirements for sample size, taking into account resources available and ethical, reductionist animal use. Animal studies were not performed in a blinded fashion. Animals were assigned randomly to experimental groups. The number of animals shown in each figure is indicated in the legends as n = x mice per group. Skin inflammation models. The dorsal skin of 8-week-old mice in the telogen (resting) phase of the hair cycle were shaved with clippers and then subjected to topical application or treatment of the skin as below.
IMQ: mice were treated with either ~ 1 mg cm −2 skin of 5% IMQ cream (Perrigo) or control Vanicream (Pharmaceutical Specialties Inc.) for 6 consecutive days as previously described 6 . Epidermal abrasion wounds: mice were treated with depilatory agent Nair (Church & Dwight). A 2 cm 2 area was then wounded shallowly with a rotary drill (Model 520 Dremel) as previously described 11 to remove the epidermis and induce re-epithelialization of the wounded skin.
TPA: mice were topically treated with 40 nM TPA (Sigma-Aldrich) in acetone per 3 cm 2 skin area or with acetone alone daily for 5 consecutive days Lineage tracing. At 8 weeks of age during the telogen (resting) phase of the hair cycle, mice were treated with 10 μ g ml −1 of 4-hydroxytamoxifen in corn oil (Sigma-Aldrich) by intraperitoneal injection for 3 consecutive days at the following doses: 10 μ g 4-hydroxytamoxifen for Krt14-creER;RosaYFP mice, and 100 μ g 4-hydroxytamoxifen for Krt10-creER;RosaYFP mice. Two days after the last tamoxifen treatment, the dorsal skin of a cohort of mice was analysed for YFP expression by flow cytometry and immunofluorescence (day 0 time point). After confirmation of YFP expression, the remaining cohort mice were treated with the aforementioned IMQ regimen and analysed at days 6, 30 and 180 after treatment. EdU pulse. For 5′ -ethynyl-2′ -deoxyuridine (EdU) pulse experiments, mice were injected intraperitoneally (50 μ g g ) (Sigma-Aldrich) at specified intervals (typically 1-4 h) before analysis. Punch biopsy and splint wounds. The dorsal skin of mice was shaved at indicated time points after IMQ treatment. After visually confirming that hair follicles in the shaved area were in the telogen (resting) phase of the hair cycle, 6 mm biopsy punches (Miltex) were used to make full-thickness wounds. Wound closure was assessed macroscopically with an engineer's caliper daily. 3 mm wounds were splinted with 8 mm silicone splints as previously described 14 . Wound closure was assessed macroscopically with an engineer's caliper daily. Wound area was calculated by applying the area of an ellipse (π × r1 × r2) to the two diameter measurements on the y axis, and x axis of the wound. One-, two-and three-phase decay model of curve fitting was performed for wound healing assays. The two-and three-phase decay analyses showed minimal contributions from second (k slow control = 0.00015; post-inflammation = 0.0017) phase and generated an 'ambiguous fit' error indicating wide confidence intervals and that the software (PRISM GraphPad) is unable to find a unique curve to fit the data. Therefore, wound healing rate constants were calculated using a one-phase decay model (PRISM GraphPad). Diptheria toxin administration. Mice were intraperitonially injected with 200 ng of diptheria toxin (Sigma Aldrich) twice daily for 5 consecutive days. Mice were maintained on a sulfatrim diet and 0.5 mg ml −1 oral fluconazole (Citron Pharma) supplemented in drinking water throughout the course of treatment and subsequent wounding experiment. Caspase inhibitor administration. Mice were intraperitonially injected with 0.6 mM Ac-YVAD-cmk (Caymon Chemicals) 29,38 1 day before wounding and then daily for the first 5 days of the wound response. Clodronate liposome administration. Mice were intraperitonially injected with either 200 μ l clodronate or control liposomes (http://www.clodronateliposomes.org) 8 day before wounding, and then every 2 days until wounding. Anti-IL-1R1 administration. Mice were intraperitonially injected with 0.2 μ g anti-IL-1R1 antibody (JAMA-147) or Armenian Hamster Isotype control (BioXCell) 1 day before wounding and then daily for the first 5 days of the wound response. In utero lentiviral transduction. Transductions were achieved by in utero injection of lentivirus into the amniotic sacs of embryonic day (E) 9.5 mice 22 . At E9.5, the surface ectoderm exists as a single layer of unspecified K14 + EpSC progenitors, which become stably transduced by lentiviral within 24 h. High lentiviral titres enable highly efficient and selective transduction of the entire embryonic skin epithelium, without affecting other skin cell types. In utero injections are noninvasive and do not alter embryonic development or elicit inflammatory responses in the skin. The DNA carried by the lentivirus is stably propagated into adulthood within the skin epithelium, including the epidermis and hair follicles. In utero lentiviral deliveries were used for all ATAC-seq peak reporters and for delivery of TRE-Aim2 expression. Doxycycline feed administration. Mice transduced with TRE-Aim2 lentivirus were placed on 2 mg kg −1 doxycycline feed (Bioserv) at postnatal day 53, and maintained on a doxycycline diet throughout the course of wound repair. Cell isolation and tissue processing. Keratinocyte isolation was adapted from a previously described protocol 39 . In brief, dorsal skin was shaved and digested using either 0.25% trypsin/EDTA (Gibco) or collagenase (Sigma) to obtain a single-cell suspension. Immune cells from 1 cm 2 pieces of skin were isolated after digestion with liberase (Roche) based on an adapted protocol 13 . To isolate wound edge epithelial stem cells, 0.5 mm 2 of skin adjacent to wound was excised and digested in collagenase. In vitro explant migration assay. The in vitro explant migration assay was performed as previously described 13 . 2 mm punch biopsies (Miltex) were taken from the back skin after hair depilation. The skin was adhered to the bottom of a fibronectin-coated plate with matrigel (Corning) and cultured in 300 μ M Ca 2+ keratinocyte growth media made as previously described 40 . Explants supplemented with recombinant IL-18 and IL-1β (Peprotech) received 50 ng ml −1 of the cytokine daily. Outgrowth of K14 + cells from explants was imaged at indicated time-points using the 10× objective of a Nikon Eclipse TS100 microscope equipped with an Exfo X-Cite Series 120 and a Hamamatsu ORCA-ER Digital Camera. Images were analysed with ImageJ software. Flow cytometry and cell sorting. Female mice were used for sorting experiments at all time points and conditions to obtain maximal cell numbers. Single-cell suspensions were stained with antibodies (Extended Data Table 1) at predetermined concentrations in a 100 μ l staining buffer (PBS containing 5% FBS and 1% HEPES) per 10 6 cells. Stained cells were re-suspended in 4′ ,6-diamidino-2-phenylindole (DAPI) in FACS buffer (Sigma-Aldrich) before analysis. Data were acquired on LSRII Analyzers (BD Biosciences) and then analysed with FlowJo program. FACS was conducted using Aria Cell Sorters (BD Biosciences) into either staining buffer or Trizol LS (Invitrogen). Immunofluorescence and image analysis. Immunofluorescence staining protocols were adapted from previously described methods 13 . In brief, tissue was fixed in 4% paraformaldehyde in PBS for 20 min at room temperature or 4 h at 4 °C. Tissue was washed three times with PBS and switched to 20% sucrose overnight and subsequently washed. Tissue was then embedded in OCT (Tissue Tek), frozen and cryosectioned (14-20 μ m). Sections were permeabilized, blocked and stained with primary and then secondary fluorescence conjugated antibody. Nuclei were stained using DAPI. EdU and TUNEL Click-It reaction were performed according to manufacturer's directions (Life Technologies). For pSTAT3 immunofluorescence, sections were fixed in methanol for 20 min at − 20 °C before primary and secondary antibody labelling. For a complete list of antibodies, see Extended Data Fig. 2d ). Data were analysed using ImageJ Software. Confocal microscopy and image processing. Images were acquired with an AxioOberver.Z1 epifluorescence microscope equipped with a Hamamatsu ORCA-ER camera and an ApoTome.2 (Carl Zeiss) slider. Tiled and stitched images of sagittal sections were collected using a 20× or 40× objective, controlled by Zen software (Carl Zeiss). Maximal projection Z-stacks are presented and co-localizations were interpreted only in single Z-stacks. Z-stacks were projected Article reSeArcH using ImageJ software. RGB images were assembled in Adobe Illustrator CC2015.3. Histology. Skin tissue was fixed in PBS containing 10% formalin, paraffin embedded, sectioned (0.8 mm) and stained with haematoxylin and eosin by Histowiz Inc. Stained slides were scanned at 40× magnification using Aperio AT2. Slides were visualized and epidermal thickness was analysed using Aperio Image Scope software. Gross images. Animals were imaged using a Leica DFC310 FX fitted with a Schott Fostec Ace fibre optic light source and a Leica microscope video lens objective 0.63× number 10447367. RNA purification, quantitative PCR and RNA sequencing. Quantitative PCR (qPCR): Individual animals were used for qPCR experiments. Total RNA was purified from either whole skin biopsies, flash frozen and then homogenized with a Bessman Tissue Pulverizer (SpectrumTM) or FACS-purified keratinocyte populations using Direct-zol RNA MiniPrep kit (Zymo Research) as per manufacturer's instructions. Equal amounts of RNA were reverse-transcribed using the superscript VILO cDNA synthesis kit (Invitrogen). cDNAs for each sample were normalized to equal amounts using primers against Actb. XpressRef Universal Total RNA (Qiagen) was used as a negative control to assess FACS population purity. For a complete list of qPCR primers, see Extended Data Table 1 .
RNA sequencing (RNA-seq): 4 animals were pooled per condition in duplicate, for each RNA-seq experiment. Total RNA was isolated from FACS-purified keratinocyte populations using Direct-zol RNA MiniPrep kit (Zymo Research) as per manufacturer's instructions. Quality of the RNA for sequencing was determined using Agilent 2100 Bioanalyzer; all samples used had RNA integrin numbers (RIN) > 9. Poly-A selection and library preparation using Illumina TrueSeq mRNA sample preparation kit and sequencing on Illumina HiSeq 2500 or HiSeq 4000 machines was performed by Weill Cornell Medical College Genomic Core facility. Fifty-base pair single-end FASTQ sequences were aligned to the mouse genome (GRCm38/mm10) using STAR 41 , and transcripts were annotated using Gencode release M9. Differential gene expression analysis was performed using DESeq2 package 42 using the gene counts output from STAR read aligner 42 . Ingenuity pathways analyses were performed on differentially expressed genes 12 h after wounding. Abbreviated pathways are presented in Fig. 4e . Complete terms are as follows: granulocyte adhesion and diapedesis; inflammasome pathway signalling; graft-versus-host disease signalling; LXR/RXR activation; role of osteoblasts, osteoclasts and chondrocytes in rheumatoid arthritis; TREM1 signalling; regulation of cytokine production in intestinal epithelial cells by IL-17A/F; hepatic cholestasis; allograft rejection signalling; and Cdc42 signalling. ATAC-seq. The ATAC-seq assay was performed on 100,000 FACS-purified cells as previously described 18, 43 . In brief, cells were lysed in ATAC lysis buffer for 5 min and then transposed with TN5 transposase (Illumina) for 30 min. Samples were barcoded and the sequencing library was prepared according to manufacturer's guidelines (Illumina) and sequenced on an Illumina HiSeq 2500.
For sequencing data analysis 50-bp paired-end FASTQs were aligned to the mouse genome (GRCm38/mm10) as previously described 43 . Correlation between replicates was measured by first calling peaks in each replicate, merging the peak sets, and then plotting the log 2 -transformed signal against individual replicates. Aligned reads for the two replicates were then merged and peaks called on the merged data set. Genomic annotation of peaks was performed using the cis-regulatory element annotation system (CEAS) 44 . Average ATAC signals for TSSs (± 3,000 bp) and for chromatin insulator protein CTCF sites (± 1,000 bp) were plotted for each sample CTCF sites were derived from CTCF peaks called in E14.5 C57BL/6 limb embryo from ENCODE (accession ENCFF001YAK) and converted to mm10 coordinates using liftOver. Average tag count is calculated by averaging the number of reads overlapping each base pair per million mapped reads; (number of reads at each base pair)/ (total read counts × 10 6 ). The x axis shows the distance from either the CTCF of TSS site.
ATAC-seq peaks were determined algorithmically using model-based analysis of ChIP-seq 2 (MACS2) algorithm with the option '-keep-dup all' to keep duplicates generated by combining experimental replicates 45 . Each peak is of varying size representing regions of signal enrichment over the background. Shared peaks were defined as regions that had at least 1 bp overlap between the two datasets. Unique peaks were then defined as regions that had no overlap. Regions where signal intensity did not meet the threshold (FDR < 0.01) for statistical significance over background were considered 'closed' .
Z-score transformations were performed to normalize data across various samples and time points. ATAC signals per base pair over the mouse genome (GRCm38/mm10), excluding the mitochondrial and Y chromosome, were scored and then averaged over 500-bp non-overlapping genomic windows. The background signal was then filtered out by excluding genomic windows that averaged less than 1 in any replicates. Data were clustered using Cluster 3.0 and visualized using GENE-E software 46 . Significantly different windows were assayed between samples by t-test (P < 0.05).
Sequencing data tracks were presented using University of California Santa Cruz genome browser 47 . Unique peaks at from day 6 and 30 control and IMQ-treated EpSCs, and overlapping peaking from day 6 and 30 IMQ-treated EpSCs were subjected to ontology analysis using Genomic Regions Enrichment of Annotation Tool (GREAT) 20 with the whole mouse genome (GRCm38/mm10) as the background. PANTHER pathways analysis was used to compare peak-associated genes with known pathways. Abbreviated terms are presented in Fig. 3d . Complete terms are as follows: apoptosis signalling pathway; PDGF signalling pathway; histamine H1 receptor-mediated signalling pathway; Notch signalling pathway; thyrotropin-releasing hormone receptor signalling pathway; oxidative stress response; oxytocin receptor-mediated signalling pathway; muscarinic acetylcholine receptor 1/3 signalling pathway; interleukin signalling pathway; Ras pathway; angiotensin II signalling through G proteins and β -arrestin; and PI3 kinase pathway. Motif analysis of these regions was performed using HOMER software (Fig. 4c) were PCR-amplified from keratinocytes genomic DNA and cloned into a pLKO-PGK-H2B-mRFP1-'Peak'-minSV40-eGFP vector 3 . After sequence verification, individual plasmids were packaged into a lentivirus injected in utero into the amniotic sacs of E9.5 C57BL/6 embryos, as described earlier. Inducible Aim2 mice. Mouse Aim2 cDNA was amplified from FACS-purified EpSCs and cloned downstream of the TRE and minimal promoter of the pLKO-TRE-PGK-H2BmRFP1 vector 3 .After sequence verification, the plasmid was packaged into a lentivirus for in utero injection into the amniotic cavity of K14rtTA E9.5 embryos. Aim2 induction was verified by qPCR 7 days after doxycycline administration to activate rtTA, which in turn binds to the TRE element. CASP1 fluorometric assay and cytokine ELISAs. Tissue lysates from 0.5 mm 2 wound edge skin 12 h after injury were prepared by freeze thawing and then dissociating tissue with a tissue lyser (Qiagen). Lysates were assayed for CASP1 activity and cytokine levels. CASP1/ICE fluorometric assay (R&D) and IL-1β (eBioscience) and IL-18 (MBL international) ELISAs were performed according to manufacturer's instructions. Tissue caspase activity is reported as units based on the recombinant human CASP1 (Sigma-Aldrich) standard. All assays were normalized to total protein levels in lysate as measured by Pierce BCA Protein Assay Kit (ThermoFisher). Statistics. Data are mean ± s.e.m. or mean ± 95% confidence interval. Group sizes were determined on the basis of the results of preliminary experiments. Mice were assigned at random to groups. Experiments were not performed in a blinded fashion. Statistical significance for all wound-healing studies was determined using the two-tailed unpaired Student's t-test, with a 95% confidence interval under the untested assumption of normality. Within each group, there was an estimate of variation, and the variance between groups was similar. Statistical significance of ATAC-seq peak and peak-gene comparisons was calculated using either a MannWhitney test or random permutation. Significant enrichment of transcription factor motifs was determined by cumulative binomial distributions. Significance of ingenuity pathways analysis was determined by right-tailed Fisher's exact test. Statistical analysis was calculated using Prism software (GraphPad), DESeq2, ingenuity pathways analysis or in R. Data availability. All datasets generated and/or analysed during the current study are presented in this published article or the accompanying Source Data or Supplementary Information files, or are available from the corresponding authors upon reasonable request. Genomic datasets generated during and/or analysed during the current study are available in the Gene Expression Omnibus (GEO) repository under accession GSE92967. + keratinocytes. Data are mean ± s.e.m. n denotes the number of biologically independent animals per group. Significance for all plots was determined using two-tailed t-test at 95% confidence interval. All experiments have been replicated at least twice. Note, relative to two-or three-phase decay models (not shown), the data (shown at right) best fit the one-phase decay model, and this was therefore used for all subsequent wound repair data. b, Temporal wound closure analysis overlaid with one-phase decay analysis at day 180 after inflammation (n = 3). c, Temporal wound closure analysis overlaid with one-phase decay analysis of skin at day 30 after treatment with a variety of different inflammation-inducing agents: MC903, TPA, epidermal abrasion (wound), or fungal infection (C. albicans) (n = 4). See Fig. 1c for rate constants. d, Immunofluorescence images of wound edge labelled with the following antibodies: anti-EdU to mark proliferating cells, anti-K17 to mark wound-sensitized keratinocytes, integrin α 5 to mark the migrating wound tongue that re-epithelializes the wound bed (w.b.), and K14, which marks the epidermal progenitors, expanded at the wound site. Vertical dotted lines denote the initial wound edge; arrows mark the edge of the extended epithelial tongue (n = 3). Scale bars, 100 μ m. See Fig. 1e for quantifications. e, Representative images of silicone splinted 3 mm full thickness wounds from day 30 control and post-inflamed animals (n = 4). Scale bars, 3 mm. See Fig. 1f for quantifications. f, Migration assays were performed on skin explants (see Fig. 1g ), in the presence or absence of mitomycin C for 5 days under conditions that quantitatively abrogate keratinocyte cell proliferation. Note that epidermal migration rates are similar, irrespective of whether cell proliferation was impaired (n = 3, 3 technical replicates per animal; P > 0.05, two-tailed t-test). Data are mean ± s.e.m. For individual data points in b and c, see Source Data. n denotes the number of biologically independent animals per group. All experiments have been replicated at least twice. + RORC + cells (yellow) in Rorc-DTR mice (n = 3), which activate DTR from the Rosa26 locus only in RORC + cells. h, Wounds heal faster in post-inflamed skin despite ablation of skin RORC + cells (n = 3). For corresponding rate constants in e-g, see Fig. 2f . i, Despite the absence of T and B cells, Rag2-null mice still mount a response to IMQ and display an accelerated wound-healing response after returning to homeostasis at day 30 post-inflammation (n = 3). For rate constants, see Fig. 2h . Scale bars, 100 μ m (d) and 50 μ m (g). Data are mean ± s.e.m. For individual data points in a, h and i, see Source Data. n denotes the number of biologically independent animals per group. Significance for all plots was determined using a two-tailed t-test at 95% confidence interval. All experiments have been replicated at least twice. ). c, qPCR validation of EpSC purity (left) using total mouse RNA as a control (right). Trp63 and Klf5 are specific for EpSCs; the others are not expressed by EpSCs (n = 3 mice pooled per group). d, Density plots depicting enrichment of ATAC-seq signals at TSSs ± 3 kb and around CTCF factor-binding sites. The x axis depicts respective distance ± 1 kb from each of these domains.
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e, Distribution of ATAC-seq peaks within defined genomic regions. UTR, untranslated regions of predicted mRNAs. f, Genomic browser shots of peaks enriched in EpSC-specific genes Klf5 and Krt14 and unaffected by IMQ. Arrows denote direction of transcription. g, Top, absolute numbers of ATAC-seq peaks from day 6 inflamed, day 30/180 post-inflamed and control EpSCs. Bottom, numbers and frequencies of ATAC-seq peaks that are shared in day 6 inflamed and either day 30 or day 180 post-inflamed EpSCs. h, Transcription factor motif enrichment (cumulative binomial distributions, P < 10 −12 ) within the ATAC-seq peaks of day 6 inflamed EpSCs (n ≥ 3). For further details, see Fig. 3a -e. n denotes the number of biologically independent animals per group. All experiments have been replicated at least twice. For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
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Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
There are no restrictions on availability of materials.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Commercial and in house (Fuch lab) generated antibodies targeted were used. Antibodies were validated by flow cytometry or immunoflouresence. For complete list of antibodies see Extended Data Table 2 
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
The following mouse strains were purchased from the Jackson Laboratories: C57BL/6, B6.FVB-Tg(Rorc-Cre)1Litt/J (Rorc-Cre), C57BL/6-Gt(ROSA), 26Sortm1(HBEGF)Awai/J B6-Rosa26iDTR, B6.129P2-Aim2Gt(CSG445)Byg/J, B6.129S7-Il1r1tm1Imx/J, and B6.129P2-Il18tm1Aki/J. Tg(Rorc-EGFP)Ebe mice were a kind gift from Dr. Gerard Eberl (Institut Pasteur). Tg(Ly6a-cre)1Isg mice were a kind gift from Dr. Isidro Sanchez-Garcia. Krt14CreER7 and Krt14rtTA mice were previously generated in the Fuchs lab. Krt10CreER transgenic mice were generated in the Fuchs lab for this study Policy information about studies involving human research participants
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N/A
